Abstract: Apparatuses and methods for adjusting deactivation voltages are described herein. An example apparatus may include a voltage control circuit. The voltage control circuit may be configured to receive an address and to adjust a deactivation voltage of an access line associated with a target group of memory cells from a first voltage to a second voltage based, at least in part, on the address. In some examples, the first voltage may be lower than the second voltage.

Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Abstract: Embodiments of the invention relate to virtual link aggregation. One embodiment includes forming one or more virtual links using physical links connecting a first networking element, a second networking element and a third networking element. A first trigger status indication is used for blocking network traffic for avoiding traffic loops occurring over the one or more virtual links.

Abstract: Embodiments of the invention relate to virtual link aggregation. One embodiment includes forming one or more virtual links using physical links connecting a first networking element, a second networking element and a third networking element. A first trigger status indication is used for blocking network traffic for avoiding traffic loops occurring over the one or more virtual links.

Abstract: The present disclosure discloses method and device for prompting program uninstallation and belongs to the field of the Internet. The method comprises: performing a security assessment of an application program installed on a mobile terminal, thereby obtaining a security assessment result; obtaining security identification information corresponding to the security assessment result based on pre-stored correlations between security assessment results and security identification information; establishing a correlation between the obtained security identification information and the application program, and displaying the correlation to a user.

Abstract: This discloses a software-sharing method among terminals. The method includes: receiving a request transmitted by a second terminal to obtain a second shared software installation package; obtaining, in accordance with the shared software ID, a default software installation package corresponding to the shared software ID; generating the second shared software installation package in accordance with the default software installation package and an sharing party ID; transmitting the second installation package to the second terminal, allowing installation at the second terminal the shared software using the second installation package. Also disclosed is a server including: a software installation package acquisition request obtaining module, a shared software installation package transmitting module, a shared software installation package generating module, and a default software installation package obtaining module.

Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.

Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Abstract: The present invention relates to novel compounds of formula (A): in the form of a free base or of an addition salt with an acid. The invention also relates to process of preparation of compounds of formula (A), to composition comprising them and to their application in therapeutics and in particular in cancers.

Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.

Abstract: This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections.

Abstract: A method is utilized for repairing a motherboard with a defective dual inline memory module (DIMM) socket mounted thereon be surface mounted technology (SMT). The method includes following steps. Repair tools including a ball grid array (BGA) rework device, a steel bar, a nozzle, and a steel sheet are provided. The BGA rework device, the nozzle are align with the defective DIMM on the motherboard for heating up solder balls between the defective DIMM and the motherboard until the solder balls are melted. The defective DIMM is removed from the motherboard. The steel bar is installed on a replacement DIMM to detect a planarity of a bottom face of the replacement DIMM. The replacement DIMM is mounted on the motherboard to replace the defective DIMM if the replacement DIMM is qualified.

Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.

Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Abstract: Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof:

Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.

Abstract: The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula (I).

Abstract: The present invention relates to novel compounds of formula (A): in the form of a free base or of an addition salt with an acid. The invention also relates to process of preparation of compounds of formula (A), to composition comprising them and to their application in therapeutics and in particular in cancers.